Concepedia

Peter Masci

PM

3

Publications

501

Citations

3

H-Index

2017

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Mayo Clinic Hospital

Mayo Clinic in Arizona

Peter Masci is an author at The University of Texas MD Anderson Cancer Center specializing in cancer research, medicine, and oncology.

Top concepts

Publications per year

2017–2021

3

Publications

3

Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers

Rachna T. Shroff, Milind Javle, Lianchun Xiao et al. · JAMA Oncology · 2019 · 460 citations · Full text

A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma

Daniel H. Ahn, Pedro Luiz Serrano Usón, Peter Masci et al. · Investigational New Drugs · 2021 · 27 citations

, , +9

A phase II trial of gemcitabine (G), cisplatin (C), and nab-paclitaxel (N) in advanced biliary tract cancers (aBTCs).

Rachna T. Shroff, Mitesh J. Borad, Lianchun Xiao et al. · Journal of Clinical Oncology · 2017 · 14 citations

, , +15

Rows per page

1–3 of 3